Recurrence and Outcome in Skull Base Meningiomas: Do They Differ from Other Intracranial Meningiomas?

 

 Buy Article Permissions and Reprints

ABSTRACT

Background and Objectives: Meningiomas have diverse presentations and the skull base harbors the most difficult of them to operate upon. The objective of this study was to learn whether the recurrence and outcome of these tumors may differ based on their location. Design: Consecutive admissions with intracranial meningiomas between 1999 and 2004 were considered according to their location, WHO grade, recurrence, and outcome following treatment. Results: There were 83 skull base meningiomas and 86 at other locations. In 22 cases of skull base tumors there was recurrence (26.5%), while 15% (13) of the other group showed recurrence. There was no statistically significant difference in the outcome between the two groups; though skull base lesions had a better outcome based upon a raw count. Only 5.1% of skull base meningiomas in comparison to 10.6% of non-skull base meningiomas had death or significant morbidity. Increasing age was associated with poor outcome (p < 0.001) while recurrence was a function of skull base location (p < 0.03) on logistic regression analysis. Conclusion: Skull base meningiomas can be operated upon with good outcome, which is comparable to the convexity meningiomas. Except for the increasing age, skull base location does not contribute to increased mortality or morbidity.

REFERENCES

• 1 Cushing H, Eisenhardt L. Meningiomas: their classification, regional behavior, life history, and surgical end results. In: Zülch KJ Brain Tumors: Their Biology and Pathology. New York; Springer-Verlag 1986: 380-383
  Google Scholar
• 2 Lefkowitz M A, Hinton D R, Weiss M H, Giannotta S L, Couldwell W T. Prognostic variables in surgery for skull base meningiomas.  Neurosurg Focus. 1997;  2 e2
  PubMedGoogle Scholar
• 3 Nakamura M, Samii M. Surgical management of a meningioma in the retrosellar region.  Acta Neurochir (Wien). 2003;  145 215-219
  CrossrefPubMedGoogle Scholar
• 4 McCarthy B J, Davis F G, Freels S et al.. Factors associated with survival in patients with meningioma.  J Neurosurg. 1998;  88 831-839
  CrossrefPubMedGoogle Scholar
• 5 Torp S H, Lindboe C F, Grønberg B H, Lydersen S, Sundstrøm S. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.  Clin Neuropathol. 2005;  24 170-174
  PubMedGoogle Scholar
• 6 Roser F, Samii M, Ostertag H, Bellinzona M. The Ki-67 proliferation antigen in meningiomas: experience in 600 cases.  Acta Neurochir (Wien). 2004;  146 37-44 , discussion 44
  CrossrefPubMedGoogle Scholar
• 7 Yamashita J, Handa H, Iwaki K, Abe M. Recurrence of intracranial meningiomas, with special reference to radiotherapy.  Surg Neurol. 1980;  14 33-40
  PubMedGoogle Scholar
• 8 Louis D N, Sheithauer B W, Budka H, Von Deimling A, Kepes J J. Meningiomas. In: Kluihues P, Cavenee WK Pathology and Genetics of Tumors of the Nervous System. Lyon, France; IARC Press 2000: 176-189
  Google Scholar
• 9 Mirimanoff R O, Dosoretz D E, Linggood R M, Ojemann R G, Martuza R L. Meningioma: analysis of recurrence and progression following neurosurgical resection.  J Neurosurg. 1985;  62 18-24
  CrossrefPubMedGoogle Scholar
• 10 Christensen D, Laursen H, Klinken L. Prediction of recurrence in meningiomas after surgical treatment: a quantitative approach.  Acta Neuropathol. 1983;  61 130-134
  CrossrefPubMedGoogle Scholar
• 11 Al-Mefty O, Kadri P A, Pravdenkova S, Sawyer J R, Strangeby C, Husain M. Malignant progression in meningioma: documentation of a series and analysis of cytogenic findings.  J Neurosurg. 2004;  101 210-218
  PubMedGoogle Scholar
• 12 Simpson D. The recurrence of meningiomas after surgical treatment.  J Neurol Neurosurg Psychiatry. 1957;  20 22-39
  CrossrefPubMedGoogle Scholar
• 13 Adegbite A B, Khan M I, Paine K W, Tan L K. The recurrence of intracranial meningiomas after surgical treatment.  J Neurosurg. 1983;  58 51-56
  CrossrefPubMedGoogle Scholar
• 14 Borovich B, Doron Y. Recurrence of intracranial meningiomas: the role played by regional multicentricity.  J Neurosurg. 1986;  64 58-63
  PubMedGoogle Scholar
• 15 Borovich B, Doron Y, Braun J et al.. Recurrence of intracranial meningiomas: the role played by multicentricity. Part 2: clinical and radiological aspects.  J Neurosurg. 1986;  65 168-171
  PubMedGoogle Scholar
• 16 Jääskeläinen J, Haltia M, Laasonen E, Wahlström T, Valtonen S. The growth rate of intracranial meningiomas and its relation to histology: an analysis of 43 patients.  Surg Neurol. 1985;  24 165-172
  PubMedGoogle Scholar
• 17 Mahmood A, Quereshi N H, Malik G M. Intracranial meningiomas: analysis of recurrence after surgical treatment.  Acta Neurochir (Wien). 1994;  126 53-58
  CrossrefPubMedGoogle Scholar
• 18 Mathiesen T, Lindquest C, Kihlstyrom L, Karlsson B. Recurrence of cranial base menigiomas.  Neurosurgery. 1996;  39 2-7
  CrossrefPubMedGoogle Scholar
• 19 De Jesus O, Sekhar L N, Parikh H K et al.. Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression and quality of life.  Neurosurgery. 1996;  39 915-920
  PubMedGoogle Scholar
• 20 Couldwell W T, Fukushima T, Gionnotta S L et al.. Petroclival meningiomas: surgical experience in 109 cases.  J Neurosurg. 1996;  84 20-28
  CrossrefPubMedGoogle Scholar
• 21 DeMonte F, Smith H K, Al-Mefty O. Outcome of aggressive removal of cavernous sinus meningiomas.  J Neurosurg. 1994;  81 245-251
  CrossrefPubMedGoogle Scholar
• 22 Kinjo T, Al-Mefty O, Kanaan I. Grade zero removal of supratentorial convexity meningiomas.  Neurosurgery. 1993;  33 394-399
  CrossrefPubMedGoogle Scholar
• 23 Kajiwara K, Fudaba H, Tsuha M et al.. Analysis of recurrences of meningiomas following neurosurgical resection [in Japanese, English abstract].  No Shinkei Geka. 1989;  17 1125-1131
  PubMedGoogle Scholar
• 24 Waga S, Yamashita J, Handa H. Recurrence of meningiomas [in Japanese, English abstract].  Neurol Med Chir (Tokyo). 1977;  17 203-208
  PubMedGoogle Scholar
• 25 Ayerbe J, Lobato R D, de la Cruz J et al.. Risk factors predicting recurrence in patients operated on for intracranial meningioma: a multivariate analysis.  Acta Neurochir (Wien). 1999;  141 921-932
  CrossrefPubMedGoogle Scholar
• 26 Tao W, Zhimin W, Xianhaou Y, Weiguo C. Multivariate analysis of recurrence in meningioma.  The Chinese-German Journal of Clinical Oncology. 2005;  4 26-29
  PubMedGoogle Scholar
• 27 Nakasu S, Nakajima M, Matsumura K I, Nakasu Y, Handa J. Meningioma: proliferating potential and clinicoradiological features.  Neurosurgery. 1995;  37 1049-1055
  CrossrefPubMedGoogle Scholar
• 28 Langford L A, Cooksley C S, DeMonte F. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas.  Hum Pathol. 1996;  27 350-354
  CrossrefPubMedGoogle Scholar
• 29 Prayson R A. Malignant meningioma: a clinicopathologic study of 23 patients including MIB-1 and p53 immunohistochemistry.  Am J Clin Pathol. 1996;  105 719-726
  PubMedGoogle Scholar
• 30 Lanzafame S, Torrisi A, Barbagallo G et al.. Corrrelation between histological grade, MIB-1, and recurrence in 69 completely resected primary intracranial meningiomas with a 6-year mean follow-up.  Pathol Res Pract. 2000;  196 483-488
  PubMedGoogle Scholar
• 31 Vannemreddy P, Nanda A, Fowler M, Nordberg M L. Skull Base Meningiomas: Do They Have a Higher Proliferation Potential for Aggression?. Paper presented at: North American Skull Base Society Annual Meeting February 16-19, 2006 Phoenix, AZ;
  Google Scholar
• 32 Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M. Swedish Interphone Study Group . Risk of brain tumors associated with exposure to exogenous female sex hormones.  Am J Epidemiol. 2006;  164 629-636
  CrossrefPubMedGoogle Scholar

Anil NandaM.D. F.A.C.S. 

Department of Neurosurgery, LSU Health Sciences Center

1501 Kings Highway, PO Box 33932, Shreveport, LA 71130-3932

Email: ananda@lsuhsc.edu